Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Jun;22(6):537-8.
doi: 10.1111/cns.12565.

A Point-by-Point Response to Braillon

Benjamin Rolland  1   2 , François Paille  1   3 , Claudine Gillet  1   4 , Alain Rigaud  1   5   6 , Romain Moirand  1   7   8 , Corine Dano  1   9 , Maurice Dematteis  1   10 , Karl Mann  11   12 , Henri-Jean Aubin  1   12   13
Affiliations
Comment

A Point-by-Point Response to Braillon

Benjamin Rolland et al. CNS Neurosci Ther. 2016 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Comment on

References

    1. Braillon A. The French Alcohol Society and European Federation of Addiction Societies: Alcohol dependence and Bigpharma dependence. CNS Neurosci Ther 2016. - PMC - PubMed
    1. Rolland B, Paille F, Gillet C, et al. Pharmacotherapy for alcohol dependence: The 2015 recommendations of the French Alcohol Society, issued in partnership with the European Federation of Addiction Societies. CNS Neurosci Ther 2016;22:25–37. - PMC - PubMed
    1. Palpacuer C, Laviolle B, Boussageon R, Reymann JM, Bellissant E, Naudet F. Risks and benefits of nalmefene in the treatment of adult alcohol dependence: A systematic literature review and meta‐analysis of published and unpublished double‐blind randomized controlled trials. PLoS Med 2015;12:e1001924. - PMC - PubMed
    1. Mann K, Bladström A, Torup L, Gual A, van den Brink W. Extending the treatment options in alcohol dependence: A randomized controlled study of as‐needed nalmefene. Biol Psychiatry 2013;73:706–713. - PubMed
    1. Gual A, He Y, Torup L, van den Brink W, Mann K; ESENSE 2 Study Group . A randomised, double‐blind, placebo‐controlled, efficacy study of nalmefene, as‐needed use, in patients with alcohol dependence. Eur Neuropsychopharmacol 2013;23:1432–1442. - PubMed

LinkOut - more resources